Tag: Telomir Pharmaceuticals
Telomir Pharmaceuticals, Inc. ($TELO) Highlights Telomir-1’s Superior Efficacy Over Standard Cancer Drugs
Telomir Pharmaceuticals, Inc. (TELO) revealed groundbreaking preclinical results demonstrating Telomir-1’s power to reverse epigenetic gene silencing in aggressive human prostate cancer cells, outperforming Paclitaxel...